A common probiotic cut jaw bone loss by 39% in mice with gum disease

If you have been told you have bone loss around your teeth, you already know how few tools exist to reverse it. Periodontitis, the advanced form of gum disease, is not just a dental nuisance: it destroys the bone and connective tissue that anchor teeth, and it does so largely in silence until the damage is substantial. Emerging research suggests the gut microbiome may play a role in how that destruction unfolds, and a new mouse study published in the journal Dentistry Journal adds a striking early data point: oral supplementation with the probiotic bacterium Bacillus subtilis reduced alveolar bone loss (the loss of the jawbone supporting the teeth) by 39% compared with untreated animals with induced gum disease.

Key takeaways:

• In mice with ligature-induced periodontitis, daily oral Bacillus subtilis supplementation was linked to 39% less jaw bone loss than untreated periodontitis controls.
• The probiotic group also showed 88.8% higher serum vitamin D metabolite levels and markedly better intestinal structure, suggesting a gut-to-bone signalling pathway worth investigating.
• This is early-stage, investigational mouse research: no causal mechanism has been confirmed, and human evidence for this specific approach does not yet exist.
• Readers managing gum disease should not take this as a reason to self-supplement; it is a signal to watch the research and discuss gut health with their care team.

Bacillus subtilis supplementation reduced alveolar bone loss by 39% in mice

The study, led by Zhang Y, Ekuni D, and colleagues at Okayama University, tested what happens when you give a spore-forming probiotic bacterium, Bacillus subtilis (BS), to mice that already have experimentally induced periodontitis. Twenty-four young male mice were divided into four groups: a healthy control group, a periodontitis-only group, a BS-only group, and a BS-plus-periodontitis group. Periodontitis was induced by tying a silk ligature around the upper second molars, a standard method for creating reproducible gum disease in rodents. The BS group received a daily oral dose of one billion colony-forming units for 18 consecutive days starting after periodontitis had been established.

The headline result was the cementoenamel junction-to-alveolar bone crest (CEJ-ABC) distance, the standard measure of how much jawbone has been destroyed. In the BS-plus-periodontitis mice, that distance was 39% shorter than in the untreated periodontitis animals, meaning substantially less bone had been lost. A separate finding drew equal attention: serum vitamin D metabolite concentrations in the probiotic-treated group were 88.8% higher than in the periodontitis-only animals, hinting at a gut-to-bone axis that may have practical importance.

Why this matters for the 4 in 10 adults already living with periodontitis

Periodontitis affects roughly 4 in 10 US adults over age 30, and globally the numbers are even starker: periodontal diseases affect an estimated 20 to 50% of the world's population and are independently linked to diabetes, cardiovascular disease, and Alzheimer's disease. Once alveolar bone is lost, it does not reliably regenerate on its own. Current treatment, scaling, root planing, and in some cases surgery, can slow progression but cannot predictably rebuild what is gone.

That is why the gut-bone connection in this study is worth paying attention to, even at this early stage. The researchers observed that the same probiotic that reduced bone loss also improved the structural integrity of the small intestine: villus height (the finger-like projections that absorb nutrients) was 58.2% greater in probiotic-treated periodontitis mice, and the villus-to-crypt ratio, a marker of overall intestinal health, was 75.9% higher compared with untreated periodontitis animals. The gut microbiome itself shifted: both alpha diversity (the variety of bacterial species within an animal) and beta diversity (the difference in community composition between groups) were statistically distinct in the probiotic group, with the bacterial families Lachnospiraceae and Bacteroidota appearing to drive much of that difference.

How the researchers set up the experiment

The ligature-induced periodontitis model, the standard method used here, is well-validated for producing rapid, measurable bone loss in a controlled timeframe, though as research on humanized mouse models notes, the immune system differences between mice and humans mean findings do not translate automatically. The team used 16S rDNA sequencing of fecal samples to profile gut bacterial communities, an ELISA assay to measure vitamin D metabolites in blood, and hematoxylin-and-eosin-stained gut tissue sections to assess intestinal morphology. Alveolar bone loss was measured from photographs of methylene blue-stained jawbones using ImageJ software. The BS dose, one billion CFU per day, was chosen based on prior rodent studies.

What this could mean if you are managing gum disease

If you have periodontitis, the gut-bone connection this study points toward is worth understanding, even though no clinical recommendation flows from mouse research. The hypothesis being tested is that a healthier gut microbiome might improve nutrient absorption (including vitamin D, which is essential for bone metabolism), reduce systemic inflammation, and by doing so, slow the inflammatory cascade that destroys periodontal bone. That chain of reasoning is biologically plausible and consistent with what is already known about the oral-gut axis.

What remains unproven: whether Bacillus subtilis supplements produce the same gut changes in humans, whether any gut improvement would translate to measurable protection of tooth-supporting bone, and what dose or duration would be relevant. Broader clinical evidence for probiotics and oral health in humans remains largely based on small, short-duration pilot studies. A separate line of evidence from an earlier human study did find that a Bacillus subtilis mouth rinse reduced periodontal pathogens in patients with periodontitis, which suggests the bacterium can interact meaningfully with oral disease, but the mechanism and route of delivery are different from the oral supplementation tested here.

If you are actively managing gum disease, this is not a signal to buy a probiotic. It is a signal to ask your dentist and primary care provider whether your gut health, vitamin D levels, and systemic inflammation are being considered alongside your local periodontal treatment.

Key gaps the researchers acknowledge

The study authors are candid about what is missing. The observed associations between gut microbiota shifts, improved intestinal morphology, higher vitamin D, and reduced bone loss are concurrent observations, not a confirmed causal chain. The researchers did not measure intestinal permeability, inflammatory cytokines, or the specific bone-resorbing signals (RANKL and OPG) that drive osteoclast activity. The ELISA used for vitamin D may have cross-reacted with related metabolites; more precise methods like liquid chromatography-mass spectrometry are needed. Only young male mice were used, at a single dose and duration, with a quasi-randomized group allocation rather than formal randomization.

Next steps: human trials and dose-response studies

The researchers call for follow-up work including female animals, dose-response experiments, and longer treatment periods. On the human side, a clinical trial is currently evaluating a Bacillus-species oral spray probiotic in children for dental caries prevention, which suggests the broader field of Bacillus probiotics for oral health is moving toward human testing. Whether an oral Bacillus subtilis supplement specifically for periodontitis will reach clinical trials depends on whether mechanistic studies can first establish how the gut-to-bone pathway works and confirm it is active in humans.

Common questions

Can I take a Bacillus subtilis probiotic to protect my gums? Not on the basis of this study. The research was done in mice under experimentally controlled conditions, and no human trial has tested this approach for gum bone loss. Speak with your dentist before adding any supplement to a periodontal treatment plan.

What is the gut-alveolar bone axis? It is the proposed signalling pathway by which changes in the gut microbiome, intestinal health, and nutrients like vitamin D affect bone metabolism in the jaw. This study provides early suggestive evidence that the axis exists and is modifiable, but the mechanism has not been confirmed.

Is Bacillus subtilis safe to take orally? Bacillus subtilis has a long history of use in fermented foods and is generally regarded as safe, but dosing, formulation, and individual health context matter. This is a question for your doctor or registered dietitian, not a reason to self-medicate based on mouse data.

How is periodontitis different from gingivitis? Gingivitis is inflammation of the gums without bone loss; it is reversible with good hygiene. Periodontitis involves irreversible destruction of the bone and ligament anchoring the teeth, and it requires professional treatment to manage.

References

1. Yixuan Zhang, Naoki Toyama, Mohammad Nurhamim, et al. (2026). Oral Supplementation of Bacillus subtilis Attenuated Alveolar Bone Loss in a Mouse Model of Ligature-Induced Periodontitis. Dentistry Journal. https://doi.org/10.3390/dj14080494
2. About Periodontal (Gum) Disease | Oral Health – CDC. cdc.gov. https://www.cdc.gov/oralhealth/conditions/periodontal-disease.html
3. YONG FENG, LIYUAN XIAO, LING-LING FU, et al. (2025). Global, Regional and National Burden of Edentulism and Periodontal Diseases from 1990 to 2021: Analysis of Risk Factors and Prediction of Trends in 2050. In Vivo. https://doi.org/10.21873/invivo.13919
4. Carolina Rojas, Michelle P. García, Alan F. Polanco, et al. (2021). Humanized Mouse Models for the Study of Periodontitis: An Opportunity to Elucidate Unresolved Aspects of Its Immunopathogenesis and Analyze New Immunotherapeutic Strategies. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.663328
5. Probiotics and Oral Health – PMC – NIH. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479184/
6. S. Tsubura, H. Mizunuma, S. Ishikawa, et al. (2009). The effect of Bacillus subtilis mouth rinsing in patients with periodontitis. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-009-0790-9
7. Oral-Spray Bacillus Spore Probiotic in Preventing and Supporting Treatment of Dental Caries in Children | ClinicalTrials.gov. clinicaltrials.gov. https://clinicaltrials.gov/study/NCT07241052